Idiopathic Inflammatory Myopathies
📧 Sign up to get email alerts when something new happens for Idiopathic Inflammatory Myopathies.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-04-10Clinical Trial Update: AYLo - AutoimmunitY and Loss of y
Clinical trial AYLo from the University of Bonn investigates autoimmunity across multiple diseases and is currently recruiting.
-
CLINICAL_TRIALS research · 2025-02-11Clinical Trial Update: PRediction of DIverse Glucocorticoids ToxIcity OUtcomeS
This clinical trial update describes a study aiming to predict diverse glucocorticoid toxicity outcomes across inflammatory rheumatic diseas…
-
CLINICAL_TRIALS research · 2025-02-05Clinical Trial Update: Adult Autoimmune Myopathies (MAIA) [NA]
Clinical trial MAIA investigates adult autoimmune inflammatory myopathies. The study is currently recruiting at University Hospital, Brest.
-
CLINICAL_TRIALS research · 2024-12-05Clinical Trial Update: Optimizing Treatment on Idiopathic Inflammatory Myopathies
A clinical trial at the University of Sao Paulo is currently recruiting to investigate treatments for Idiopathic Inflammatory Myopathies.
-
CLINICAL_TRIALS research · 2024-10-30Clinical Trial Update: Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System [EARLY_Phase 1]
An early-phase clinical trial is investigating CT103A cell therapy for relapsed/refractory antibody-associated inflammatory diseases of the …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-06-26Clinical Trial Update: Drug Rediscovery for Rare Immune Mediated Inflammatory Diseases [Phase 2]
A Phase 2 clinical trial update for rediscovering a drug for rare immune-mediated inflammatory diseases, with recruitment ongoing for Behçet…
-
CLINICAL_TRIALS research · 2024-05-16Clinical Trial Update: Preliminary Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory Autoimmune Diseases [EARLY_Phase 1]
A preliminary Phase 1 study is planned to evaluate UTAA09 injections for relapsed/refractory autoimmune diseases, with recruitment not yet s…